RNA Technologies in Cardiovascular Medicine and Research /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2008.
|
| Edición: | 1st ed. 2008. |
| Materias: |
Tabla de Contenidos:
- MicroRNA
- An Overview of MicroRNA
- MicroRNAs and Their Potential
- miRNAs and Their Emerging Role in Cardiac Hypertrophy
- MicroRNAs and the Control of Heart Pathophysiology
- MicroRNA Systems Biology
- RNA Interference
- Targeting Viral Heart Disease by RNA Interference
- Design of siRNAs and shRNAs for RNA Interference: Possible Clinical Applications
- RNA Interference and MicroRNA Modulation for the Treatment of Cardiac Disorders
- Cardiac Delivery of Nucleic Acids by Transcriptional and Transductional Targeting of Adeno-Associated Viral Vectors
- Ribozymes
- Characterization of Hammerhead Ribozymes Potentially Suitable for the Treatment of Hyper-Proliferative Vascular Diseases
- Applications of Ribozymes and Pyrrole–Imidazole Polyamides for Cardiovascular and Renal Diseases
- Noncoding, Aptamer and Antisense RNAs
- Noncoding RNAs in Human Diseases
- Aptamers and siRNAs in Cardiovascular Disease
- Nucleic Acid Aptamers for Cardiovascular Therapeutics
- NF?B Decoy Oligodeoxynucleotide-Based Therapy in Cardiovascular Diseases
- Antisense Therapy for Restenosis Following Percutaneous Coronary Interventions
- Toxic RNA in Pathogenesis of Human Neuromuscular Disorders.